Research Article
Formulation and In Vitro Evaluation of Bilayer Tablets of Nebivolol Hydrochloride and Nateglinide for the Treatment of Diabetes and Hypertension
Table 3
Composition of Nateglinide sustained release tablets.
| Ingredients | N1 | N2 | N3 | N4 | N5 | N6 | N7 | N8 | N9 | N10 | N11 | N12 | N13 |
| Drug | 60 | 60 | 60 | 60 | 60 | 60 | 60 | 60 | 60 | 60 | 60 | 60 | 60 | HPMC | 30 | 45 | 60 | — | — | — | — | — | 45 | — | — | — | — | Guar gum | — | — | — | 30 | 45 | 60 | 75 | — | — | 60 | 60 | 60 | 60 | X-gum | — | — | — | — | — | — | — | 75 | 45 | 45 | — | — | — | EC | — | — | — | — | — | — | — | — | — | — | 15 | 30 | 15 | Mannitol | — | — | — | — | — | — | — | — | — | — | — | — | 72 | MCC | 180 | 165 | 150 | 180 | 165 | 150 | 135 | 135 | 120 | 129 | 135 | 120 | 72 | PVP | 15 | 15 | 15 | 15 | 15 | 15 | 15 | 15 | 15 | 15 | 15 | 15 | 15 | Mg. st. | 7.5 | 7.5 | 7.5 | 7.5 | 7.5 | 7.5 | 7.5 | 7.5 | 7.5 | 6 | 7.5 | 7.5 | 6 | Talc | 7.5 | 7.5 | 7.5 | 7.5 | 7.5 | 7.5 | 7.5 | 7.5 | 7.5 | — | 7.5 | 7.5 | — | Total wt. | 300 | 300 | 300 | 300 | 300 | 300 | 300 | 300 | 300 | 300 | 300 | 300 | 300 |
|
|
HPMC: hydroxy propyl methyl cellulose; X-gum: Xanthan gum; EC: ethyl cellulose; MCC: microcrystalline cellulose; PVP: polyvinyl pyrrolidone, Mg. st.: magnesium stearate.
|